Literature DB >> 1664345

Seroepidemiological correlations of antibodies to human herpesviruses and human immunodeficiency virus type 1 in African patients.

S Essers1, A Schwinn, J ter Meulen, H von Lips, K Dietz, F S Mhalu, J Shao, V ter Meulen.   

Abstract

A seroepidemiological evaluation of the humoral immune response against human herpes viruses was carried out in patients with and without HIV infection in Tanzania to study the role of these viruses as a cofactor in AIDS. Serum specimens were obtained from 321 outpatients and 100 healthy schoolchildren of a rural population in the Kagera Region, Tanzania, and from 149 inpatients of an urban population in Dar-es-Salaam, Tanzania. The data were analysed by logistic models taking into account demographic variables. The data obtained revealed no differences in the prevalence of antibodies to human herpes viruses between the different groups. Therefore, our study under the present conditions and the observed stages of AIDS does not suggest an influence of HIV infection on human herpesvirus infection or serologic response.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Adult; Africa; Africa South Of The Sahara; Age Factors; Antibodies; Biology; Case Control Studies; Correlation Studies; Demographic Factors; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Examinations And Diagnoses; Hematologic Tests; Herpes Genitalis; Hiv Infections; Hiv Serodiagnosis; Immunity; Immunologic Factors; Infections; Laboratory Examinations And Diagnoses; Laboratory Procedures; Methodological Studies; Physiology; Population; Population Characteristics; Reproductive Tract Infections; Research Methodology; Retrospective Studies; Rural Population; School Age Population; Sexually Transmitted Diseases; Statistical Studies; Studies; Tanzania; Urban Population; Viral Diseases

Mesh:

Substances:

Year:  1991        PMID: 1664345     DOI: 10.1007/bf00218678

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  30 in total

1.  Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.

Authors:  J Menezes; W Leibold; G Klein; G Clements
Journal:  Biomedicine       Date:  1975-07

2.  High prevalence of antibody to human herpesvirus-6 and seroconversion associated with rash in two infants.

Authors:  W A Knowles; S D Gardner
Journal:  Lancet       Date:  1988-10-15       Impact factor: 79.321

3.  Herpesviruses as co-factors in AIDS.

Authors:  S D Holmberg; A R Gerber; J A Stewart; F K Lee; P M O'Malley; A J Nahmias
Journal:  Lancet       Date:  1988-09-24       Impact factor: 79.321

4.  Age prevalence of antibody to human herpesvirus 6.

Authors:  M Briggs; J Fox; R S Tedder
Journal:  Lancet       Date:  1988-05-07       Impact factor: 79.321

5.  Association of HTLV-III with Epstein-Barr virus infection and abnormalities of T lymphocytes in homosexual men.

Authors:  C R Rinaldo; L A Kingsley; D W Lyter; B S Rabin; R W Atchison; A J Bodner; S H Weiss; W C Saxinger
Journal:  J Infect Dis       Date:  1986-10       Impact factor: 5.226

Review 6.  Overview of immunopathology of chronic active herpesvirus infection.

Authors:  G R Krueger; A Ramon
Journal:  J Virol Methods       Date:  1988-09       Impact factor: 2.014

7.  Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells.

Authors:  G J Nabel; S A Rice; D M Knipe; D Baltimore
Journal:  Science       Date:  1988-03-11       Impact factor: 47.728

8.  Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population.

Authors:  J A Levy; F Ferro; D Greenspan; E T Lennette
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

9.  Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders.

Authors:  S Z Salahuddin; D V Ablashi; P D Markham; S F Josephs; S Sturzenegger; M Kaplan; G Halligan; P Biberfeld; F Wong-Staal; B Kramarsky
Journal:  Science       Date:  1986-10-31       Impact factor: 47.728

10.  Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses.

Authors:  H E Gendelman; W Phelps; L Feigenbaum; J M Ostrove; A Adachi; P M Howley; G Khoury; H S Ginsberg; M A Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

View more
  3 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Evaluation of a new reagent for anti-cytomegalovirus and anti-Epstein-Barr virus immunoglobulin G.

Authors:  J Gutierrez; M D Maroto; G Piédrola
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

3.  Improved HIV testing coverage after scale-up of antiretroviral therapy programs in urban Zambia: Evidence from serial hospital surveillance.

Authors:  Nzali G Kancheya; Atia K Jordan; Isaac S Zulu; Duncan Chanda; Sten H Vermund
Journal:  Med J Zambia       Date:  2010
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.